CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 9.840
- +2.480+33.70%
Close May 2 16:00 ET
- 9.860
- +0.020+0.20%
Post 20:01 ET
1.49BMarket Cap-10.36P/E (TTM)
10.280High8.570Low15.57MVolume8.810Open7.360Pre Close153.45MTurnover15.60%Turnover RatioLossP/E (Static)151.92MShares10.28052wk High7.85P/B982.14MFloat Cap2.99052wk Low--Dividend TTM99.81MShs Float71.250Historical High--Div YieldTTM23.23%Amplitude2.280Historical Low9.854Avg Price1Lot Size
Adaptive Biotechnologies News
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 10-Q: Q1 2025 Earnings Report
Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Adaptive Biotechnologies | ARS: Annual Report to Security Holders
Adaptive Biotechnologies | DEFA14A: Others
Adaptive Biotechnologies | DEF 14A: Definitive information statements
Adaptive Biotechnologies | SCHEDULE 13G/A: Others
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer ROBINS HARLAN S
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director GRIFFIN MICHELLE RENEE
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director HERSHBERG ROBERT
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director NEUPERT PETER M
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer LO FRANCIS
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BOBULSKY SUSAN
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer BENZENO SHARON
Adaptive Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer PISKEL KYLE
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call